Literature DB >> 6263000

An avian sarcoma virus mutant which produces an aberrant transformation affecting cell morphology.

D J Fujita, C B Boschek, A Ziemiecki, R R Friis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6263000     DOI： 10.1016/0042-6822(81)90667-x

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  7 in total

1.  Association of type I phosphatidylinositol kinase activity with mutationally activated forms of human pp60c-src.

Authors:  T O Chan; A Tanaka; J D Bjorge; D J Fujita
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  Transformation parameters and pp60src localization in cells infected with partial transformation mutants of Rous sarcoma virus.

Authors:  L Rohrschneider; M J Rosok
Journal:  Mol Cell Biol       Date:  1983-04       Impact factor: 4.272

3.  Morphf mutants of Rous sarcoma virus: nucleotide sequencing analysis suggests that a class of morphf mutants was generated through splicing of a cryptic intron.

Authors:  S K Anderson; D J Fujita
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

4.  Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo.

Authors:  M H Feuerman; B R Davis; P K Pattengale; H Fan
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

5.  Regulation of cellular morphology by the Rous sarcoma virus src gene: analysis of fusiform mutants.

Authors:  L Rohrschneider; S Reynolds
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

6.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Phosphotyrosine-containing proteins and expression of transformation parameters in cells infected with partial transformation mutants of Rous sarcoma virus.

Authors:  J Cooper; K D Nakamura; T Hunter; M J Weber
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.